Sterling Capital Management LLC Travere Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 246 shares of TVTX stock, worth $4,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246Holding current value
$4,565% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
185Shares Held
90.4MCall Options Held
305KPut Options Held
184K-
Armistice Capital, LLC New York, NY7.65MShares$142 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$128 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$86.9 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$80.6 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.19B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...